• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺表面活性物质促分泌素可增加肺对肺泡磷脂的摄取。

Secretagogues for lung surfactant increase lung uptake of alveolar phospholipids.

作者信息

Fisher A B, Dodia C, Chander A

机构信息

Institute for Environmental Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6068.

出版信息

Am J Physiol. 1989 Oct;257(4 Pt 1):L248-52. doi: 10.1152/ajplung.1989.257.4.L248.

DOI:10.1152/ajplung.1989.257.4.L248
PMID:2801953
Abstract

This study evaluated the effect of known secretagogues for lung surfactant on the uptake of phospholipid from the aveolar space. Synthetic liposomes containing tracer [choline-methyl-3H]dipalmitoyl phosphatidylcholine (DPPC) were instilled endotracheally in anesthetized rats. Lungs were then isolated and perfused under control conditions or with addition of terbutaline (0.1 mM), ATP (1 mM), or a phorbol ester, tradecanoyl phorbol acetate (TPA, 30 ng/ml). Uptake of liposomes was defined as lavage-resistant accumulation of radioactivity in the lung. Uptake at 2 h was 18.2 +/- 0.93% of instilled radioactivity per minute (mean +/- SE, n = 4) under control conditions and was increased by 56-82% in the presence of each of the agonists (P less than 0.05). At 5 min after addition of terbutaline, uptake was unchanged but secretion of phosphatidylcholine (PC) into the alveolar space was significantly stimulated. Internalized diphosphatidylcholine was degraded to aqueous soluble metabolites and also converted to PC containing an unsaturated fatty acid, and this metabolism was significantly stimulated in the presence of each of the secretagogues. These results indicate that known secretagogues for surfactant increase uptake and metabolism of phospholipid, suggesting linkage of these processes in a physiologically regulated surfactant cycle.

摘要

本研究评估了已知的肺表面活性物质促分泌剂对肺泡腔内磷脂摄取的影响。将含有示踪剂[胆碱 - 甲基 - ³H]二棕榈酰磷脂酰胆碱(DPPC)的合成脂质体经气管内注入麻醉大鼠体内。然后分离肺脏,并在对照条件下或添加特布他林(0.1 mM)、ATP(1 mM)或佛波酯十四酰佛波醇乙酸酯(TPA,30 ng/ml)的情况下进行灌注。脂质体的摄取定义为肺内放射性物质的灌洗抗性积累。在对照条件下,2小时时的摄取量为每分钟注入放射性物质的18.2±0.93%(平均值±标准误,n = 4),在每种激动剂存在的情况下摄取量增加了56 - 82%(P<0.05)。添加特布他林后5分钟,摄取量未改变,但磷脂酰胆碱(PC)向肺泡腔的分泌受到显著刺激。内化的二磷脂酰胆碱降解为水溶性代谢产物,也转化为含有不饱和脂肪酸的PC,并且在每种促分泌剂存在的情况下这种代谢受到显著刺激。这些结果表明,已知的表面活性物质促分泌剂可增加磷脂的摄取和代谢,提示这些过程在生理调节的表面活性物质循环中存在联系。

相似文献

1
Secretagogues for lung surfactant increase lung uptake of alveolar phospholipids.肺表面活性物质促分泌素可增加肺对肺泡磷脂的摄取。
Am J Physiol. 1989 Oct;257(4 Pt 1):L248-52. doi: 10.1152/ajplung.1989.257.4.L248.
2
Regulation of lung surfactant secretion by intracellular pH.细胞内pH对肺表面活性物质分泌的调节
Am J Physiol. 1989 Dec;257(6 Pt 1):L354-60. doi: 10.1152/ajplung.1989.257.6.L354.
3
Surfactant lipid uptake and secretion in type II cells in response to lectins and secretagogues.II型细胞中表面活性剂脂质摄取及分泌对凝集素和促分泌剂的反应
Am J Physiol. 1991 Dec;261(6 Pt 1):L434-42. doi: 10.1152/ajplung.1991.261.6.L434.
4
Degradation and reutilization of alveolar phosphatidylcholine by rat lungs.大鼠肺对肺泡磷脂酰胆碱的降解与再利用
J Appl Physiol (1985). 1987 Jun;62(6):2295-9. doi: 10.1152/jappl.1987.62.6.2295.
5
Uptake of instilled radiolabeled lamellar bodies from alveolar compartment of the rat.大鼠肺泡腔中注入的放射性标记板层小体的摄取情况。
Am J Physiol. 1990 Oct;259(4 Pt 1):L238-46. doi: 10.1152/ajplung.1990.259.4.L238.
6
Inhibition of lung surfactant secretion from alveolar type II cells and annexin II tetramer-mediated membrane fusion by phenothiazines.吩噻嗪对肺泡II型细胞肺表面活性物质分泌及膜联蛋白II四聚体介导的膜融合的抑制作用。
Arch Biochem Biophys. 1997 Jun 15;342(2):322-8. doi: 10.1006/abbi.1997.0140.
7
Alveolar uptake of lipid and protein components of surfactant.肺泡对表面活性剂脂质和蛋白质成分的摄取。
Am J Physiol. 1991 Oct;261(4 Pt 1):L334-40. doi: 10.1152/ajplung.1991.261.4.L334.
8
P2-purinoceptor regulation of surfactant phosphatidylcholine secretion. Relative roles of calcium and protein kinase C.表面活性物质磷脂酰胆碱分泌的P2-嘌呤受体调节。钙和蛋白激酶C的相对作用。
Biochem J. 1990 Mar 1;266(2):407-13. doi: 10.1042/bj2660407.
9
Regulation of lung surfactant secretion by phospholipase A2.磷脂酶A2对肺表面活性物质分泌的调节
J Cell Biochem. 1999 Jan 1;72(1):103-10.
10
Signal-transduction mechanisms of ATP-stimulated phosphatidylcholine secretion in rat type II pneumocytes: interactions between ATP and other surfactant secretagogues.大鼠II型肺细胞中ATP刺激的磷脂酰胆碱分泌的信号转导机制:ATP与其他表面活性剂分泌刺激物之间的相互作用。
Biochim Biophys Acta. 1993 Mar 17;1167(1):85-93. doi: 10.1016/0005-2760(93)90221-t.

引用本文的文献

1
The serpentine path to a novel mechanism-based inhibitor of acute inflammatory lung injury.通往新型基于机制的急性炎症性肺损伤抑制剂的曲折道路。
J Appl Physiol (1985). 2014 Jun 15;116(12):1521-30. doi: 10.1152/japplphysiol.00246.2014. Epub 2014 Apr 17.
2
Mitogen-activated protein kinase-mediated phosphorylation of peroxiredoxin 6 regulates its phospholipase A(2) activity.丝裂原活化蛋白激酶介导的过氧化物酶体增殖物激活受体6磷酸化调节其磷脂酶A2活性。
Biochem J. 2009 May 1;419(3):669-79. doi: 10.1042/BJ20082061.
3
A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung.
磷脂酶A2的竞争性抑制剂可减少大鼠肺表面活性物质磷脂酰胆碱的降解。
Biochem J. 1992 Dec 1;288 ( Pt 2)(Pt 2):407-11. doi: 10.1042/bj2880407.